Recursion Pharmaceuticals shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Recursion Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Recursion Pharmaceuticals held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Recursion Pharmaceuticals by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $159k | 24k | 6.59 |
| 2024-06-30 | $152k | 20k | 7.50 |
| 2024-03-31 | $135k | 14k | 9.97 |
| 2023-12-31 | $134k | 14k | 9.86 |
| 2023-09-30 | $104k | 14k | 7.65 |
| 2023-06-30 | $84k | 11k | 7.47 |
| 2023-03-31 | $68k | 10k | 6.67 |
| 2022-12-31 | $88k | 10k | 8.71 |
| 2022-09-30 | $107k | 10k | 10.55 |
| 2022-06-30 | $82k | 10k | 8.09 |
| 2022-03-31 | $64k | 8.9k | 7.18 |
| 2021-12-31 | $153k | 8.9k | 17.18 |
| 2021-09-30 | $50k | 2.2k | 23.18 |
| 2021-06-30 | $60k | 1.7k | 36.21 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors